SlideShare a Scribd company logo
diagnostic standards for 
pulmonary embolism 
Tomasz Rakowski 
Jagiellonian University Medical College 
Krakow, Poland
Diagnosis 
Throughout these guidelines and for the purpose of clinical 
management, ‘confirmed PE’ is understood as a probability of 
PE high enough to indicate the need for PE-specific treatment 
and ‘excluded PE’ as a probability of PE low enough to justify 
withholding specific PE-treatment with an acceptably low risk 
despite a clinical suspicion of PE. These terms are not meant 
to indicate absolute certainty regarding the presence or 
absence of embolii in the pulmonary arterial bed. 
.
Severity of pulmonary embolism 
The severity of PE should be understood as an individual 
estimate of PE-related early mortality risk rather than the 
anatomical burden and the shape and distribution of 
intrapulmonary emboli. Therefore, current guidelines suggest 
replacing potentially misleading terms such as ‘massive’, 
‘submassive’ and ‘non-massive’ with the estimated level of 
the risk of PE-related early death.
Principal markers useful for risk stratification
Risk stratification according to expected pulmonary 
embolism-related early mortality rate 
a In the presence of shock or hypotension it is not necessary to confirm RV dysfunction/injury to 
classify as high risk of PE-related early mortality.
Clinical prediction rules for PE 
Revised Geneva score Wells score
Simplified clinical prediction rules for PE 
Revised Geneva score Wells score 
+1 
+1 
+1 
+1 
+1 
+1 
+1 
+1 
+1 
+1 
+1 
+1 
+1 
+1 
+1 
+1 
Low: 0 to 1; intermediate: 2 to 4; high: 5+ PE unlikely: 0 to 1; PE likely: 2 or more 
PE unlikely: 0 to 2; PE likely: 3 or more 
Thromb Haemost 2009;101:197-200 
Arch Intern Med. 2008;168:2131-6
Validated diagnostic criteria for diagnosing PE in patients 
without shock and hypotension (non-high-risk PE) 
according to clinical probability
Validated diagnostic criteria for diagnosing PE in patients 
without shock and hypotension (non-high-risk PE) 
according to clinical probability

More Related Content

Similar to Diagnostic standards for PE - prof. Tomasz Rakowski

Icaro 2015 pah e ctd cavagna
Icaro 2015 pah e ctd cavagnaIcaro 2015 pah e ctd cavagna
Icaro 2015 pah e ctd cavagna
PahPavia
 
Diagnosing heart failure in patients with & without copd
Diagnosing heart failure in patients with  & without copd Diagnosing heart failure in patients with  & without copd
Diagnosing heart failure in patients with & without copd
Imad Hassan
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolism
Mostafa Elshazly
 
Pulmonary manifestation of systemic lupus
Pulmonary  manifestation of systemic lupusPulmonary  manifestation of systemic lupus
2015 4pdates in RF - Copy.ppt.ppt
2015  4pdates in RF - Copy.ppt.ppt2015  4pdates in RF - Copy.ppt.ppt
2015 4pdates in RF - Copy.ppt.ppt
YasmeenSh2
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolism
oday abdow
 
escpe1-191229130329.pptx
escpe1-191229130329.pptxescpe1-191229130329.pptx
escpe1-191229130329.pptx
EastmaMeili1
 
2019 ESC guidelines on pulmonary embolism
2019 ESC guidelines on pulmonary embolism2019 ESC guidelines on pulmonary embolism
2019 ESC guidelines on pulmonary embolism
Saitej Reddy
 
Management of-pulmonary-embolism--a 2016-journal-of-the-american-college-of-
Management of-pulmonary-embolism--a 2016-journal-of-the-american-college-of-Management of-pulmonary-embolism--a 2016-journal-of-the-american-college-of-
Management of-pulmonary-embolism--a 2016-journal-of-the-american-college-of-
Pitchya Wangmeesri
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolism
vkatbcd
 
Assessment of operability of left to right shunts
Assessment of operability of left to right shuntsAssessment of operability of left to right shunts
Assessment of operability of left to right shunts
SR,CARDIOLOGY,JIPMER,PUDUCHERRY
 
Update on Pulmonary Embolism
Update on Pulmonary EmbolismUpdate on Pulmonary Embolism
Update on Pulmonary Embolism
Muhanad Majeed
 
CLINICAL ASSESSMENT OF COPD
CLINICAL ASSESSMENT OF COPDCLINICAL ASSESSMENT OF COPD
CLINICAL ASSESSMENT OF COPD
SoM
 
Venous thromboembolism, THROMBOPROPHYLAXIS and management
Venous thromboembolism, THROMBOPROPHYLAXIS and managementVenous thromboembolism, THROMBOPROPHYLAXIS and management
Venous thromboembolism, THROMBOPROPHYLAXIS and management
mauryaramgopal
 
Pulmonary Embolism.pptx
Pulmonary Embolism.pptxPulmonary Embolism.pptx
Pulmonary Embolism.pptx
DileepRedemption
 
pe.pptx
pe.pptxpe.pptx
2019 ESC guidelines for pulmonary embolism
2019 ESC guidelines for pulmonary embolism 2019 ESC guidelines for pulmonary embolism
2019 ESC guidelines for pulmonary embolism
Dina Mostafa
 
Patent Foramen Ovale,practical plan of handling.ppt
Patent Foramen Ovale,practical plan of handling.pptPatent Foramen Ovale,practical plan of handling.ppt
Patent Foramen Ovale,practical plan of handling.ppt
Aliaa Shaban
 
Pulmonary Embolism lecture 2022
Pulmonary Embolism lecture 2022Pulmonary Embolism lecture 2022
Pulmonary Embolism lecture 2022
Dr.Marwan Sneymeh
 
Diagnosis of Pulmonary Embolism - by Dr KD DELE
Diagnosis of Pulmonary Embolism - by Dr KD DELEDiagnosis of Pulmonary Embolism - by Dr KD DELE
Diagnosis of Pulmonary Embolism - by Dr KD DELE
Kemi Dele-Ijagbulu
 

Similar to Diagnostic standards for PE - prof. Tomasz Rakowski (20)

Icaro 2015 pah e ctd cavagna
Icaro 2015 pah e ctd cavagnaIcaro 2015 pah e ctd cavagna
Icaro 2015 pah e ctd cavagna
 
Diagnosing heart failure in patients with & without copd
Diagnosing heart failure in patients with  & without copd Diagnosing heart failure in patients with  & without copd
Diagnosing heart failure in patients with & without copd
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolism
 
Pulmonary manifestation of systemic lupus
Pulmonary  manifestation of systemic lupusPulmonary  manifestation of systemic lupus
Pulmonary manifestation of systemic lupus
 
2015 4pdates in RF - Copy.ppt.ppt
2015  4pdates in RF - Copy.ppt.ppt2015  4pdates in RF - Copy.ppt.ppt
2015 4pdates in RF - Copy.ppt.ppt
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolism
 
escpe1-191229130329.pptx
escpe1-191229130329.pptxescpe1-191229130329.pptx
escpe1-191229130329.pptx
 
2019 ESC guidelines on pulmonary embolism
2019 ESC guidelines on pulmonary embolism2019 ESC guidelines on pulmonary embolism
2019 ESC guidelines on pulmonary embolism
 
Management of-pulmonary-embolism--a 2016-journal-of-the-american-college-of-
Management of-pulmonary-embolism--a 2016-journal-of-the-american-college-of-Management of-pulmonary-embolism--a 2016-journal-of-the-american-college-of-
Management of-pulmonary-embolism--a 2016-journal-of-the-american-college-of-
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolism
 
Assessment of operability of left to right shunts
Assessment of operability of left to right shuntsAssessment of operability of left to right shunts
Assessment of operability of left to right shunts
 
Update on Pulmonary Embolism
Update on Pulmonary EmbolismUpdate on Pulmonary Embolism
Update on Pulmonary Embolism
 
CLINICAL ASSESSMENT OF COPD
CLINICAL ASSESSMENT OF COPDCLINICAL ASSESSMENT OF COPD
CLINICAL ASSESSMENT OF COPD
 
Venous thromboembolism, THROMBOPROPHYLAXIS and management
Venous thromboembolism, THROMBOPROPHYLAXIS and managementVenous thromboembolism, THROMBOPROPHYLAXIS and management
Venous thromboembolism, THROMBOPROPHYLAXIS and management
 
Pulmonary Embolism.pptx
Pulmonary Embolism.pptxPulmonary Embolism.pptx
Pulmonary Embolism.pptx
 
pe.pptx
pe.pptxpe.pptx
pe.pptx
 
2019 ESC guidelines for pulmonary embolism
2019 ESC guidelines for pulmonary embolism 2019 ESC guidelines for pulmonary embolism
2019 ESC guidelines for pulmonary embolism
 
Patent Foramen Ovale,practical plan of handling.ppt
Patent Foramen Ovale,practical plan of handling.pptPatent Foramen Ovale,practical plan of handling.ppt
Patent Foramen Ovale,practical plan of handling.ppt
 
Pulmonary Embolism lecture 2022
Pulmonary Embolism lecture 2022Pulmonary Embolism lecture 2022
Pulmonary Embolism lecture 2022
 
Diagnosis of Pulmonary Embolism - by Dr KD DELE
Diagnosis of Pulmonary Embolism - by Dr KD DELEDiagnosis of Pulmonary Embolism - by Dr KD DELE
Diagnosis of Pulmonary Embolism - by Dr KD DELE
 

More from piodof

Wyniki leczenia przezskónego asd - prof. Jacek Białkowski
Wyniki leczenia przezskónego asd - prof. Jacek BiałkowskiWyniki leczenia przezskónego asd - prof. Jacek Białkowski
Wyniki leczenia przezskónego asd - prof. Jacek Białkowski
piodof
 
Treatment of pulmonary embolism data from registries - prof. Zbigniew Gąsior
Treatment of pulmonary embolism data from registries - prof. Zbigniew GąsiorTreatment of pulmonary embolism data from registries - prof. Zbigniew Gąsior
Treatment of pulmonary embolism data from registries - prof. Zbigniew Gąsior
piodof
 
Therapeutic options for aortic stenosis in elderly - dr Jaroslaw Trębacz
Therapeutic options for aortic stenosis in elderly - dr Jaroslaw TrębaczTherapeutic options for aortic stenosis in elderly - dr Jaroslaw Trębacz
Therapeutic options for aortic stenosis in elderly - dr Jaroslaw Trębacz
piodof
 
Renal stenting and denervation - prof. Tadeusz Przewłocki
Renal stenting and denervation - prof. Tadeusz PrzewłockiRenal stenting and denervation - prof. Tadeusz Przewłocki
Renal stenting and denervation - prof. Tadeusz Przewłocki
piodof
 
Renal denervation - prof. Adam Witkowski
Renal denervation - prof. Adam WitkowskiRenal denervation - prof. Adam Witkowski
Renal denervation - prof. Adam Witkowski
piodof
 
Regenerative therapies for heart and vessels - prof. Piotr Musiałek
Regenerative therapies for heart and vessels - prof. Piotr MusiałekRegenerative therapies for heart and vessels - prof. Piotr Musiałek
Regenerative therapies for heart and vessels - prof. Piotr Musiałek
piodof
 
Patient with chronic PE treatment options - dr Szymon Darocha
Patient with chronic PE treatment options - dr Szymon DarochaPatient with chronic PE treatment options - dr Szymon Darocha
Patient with chronic PE treatment options - dr Szymon Darocha
piodof
 
Novel self expanding nitinol carotid stent - dr Krzysztof Milewski
Novel self expanding nitinol carotid stent - dr Krzysztof MilewskiNovel self expanding nitinol carotid stent - dr Krzysztof Milewski
Novel self expanding nitinol carotid stent - dr Krzysztof Milewski
piodof
 
Novel paclitaxel coated balloon - dr Piotr Buszman
Novel paclitaxel coated balloon - dr Piotr BuszmanNovel paclitaxel coated balloon - dr Piotr Buszman
Novel paclitaxel coated balloon - dr Piotr Buszman
piodof
 
New perspectives in CLI - prof. Giancarlo Biamino
New perspectives in CLI - prof. Giancarlo BiaminoNew perspectives in CLI - prof. Giancarlo Biamino
New perspectives in CLI - prof. Giancarlo Biamino
piodof
 
Limitations of carotid stenting - dr Antoni Ferens
Limitations of carotid stenting - dr Antoni FerensLimitations of carotid stenting - dr Antoni Ferens
Limitations of carotid stenting - dr Antoni Ferens
piodof
 
LAA ligation and ablation - dr Marcin Kuniewicz
LAA ligation and ablation - dr Marcin KuniewiczLAA ligation and ablation - dr Marcin Kuniewicz
LAA ligation and ablation - dr Marcin Kuniewicz
piodof
 
LAA closure - prof. Jaroslav Januska
LAA closure - prof. Jaroslav JanuskaLAA closure - prof. Jaroslav Januska
LAA closure - prof. Jaroslav Januska
piodof
 
LAA closure - dr Marek Grygier
LAA closure - dr Marek GrygierLAA closure - dr Marek Grygier
LAA closure - dr Marek Grygier
piodof
 
Hypoplastic left heart syndome - prof. Tomasz Moszura
Hypoplastic left heart syndome - prof. Tomasz MoszuraHypoplastic left heart syndome - prof. Tomasz Moszura
Hypoplastic left heart syndome - prof. Tomasz Moszura
piodof
 
Historia HLHS - prof. Janusz Skalski
Historia HLHS - prof. Janusz SkalskiHistoria HLHS - prof. Janusz Skalski
Historia HLHS - prof. Janusz Skalskipiodof
 
Generalised atherosclerosis - dr Antonio Micari
Generalised atherosclerosis - dr Antonio MicariGeneralised atherosclerosis - dr Antonio Micari
Generalised atherosclerosis - dr Antonio Micari
piodof
 
Decision making for pulmonary embolism - dr Michal Chyrchel
Decision making for pulmonary embolism - dr Michal ChyrchelDecision making for pulmonary embolism - dr Michal Chyrchel
Decision making for pulmonary embolism - dr Michal Chyrchel
piodof
 

More from piodof (18)

Wyniki leczenia przezskónego asd - prof. Jacek Białkowski
Wyniki leczenia przezskónego asd - prof. Jacek BiałkowskiWyniki leczenia przezskónego asd - prof. Jacek Białkowski
Wyniki leczenia przezskónego asd - prof. Jacek Białkowski
 
Treatment of pulmonary embolism data from registries - prof. Zbigniew Gąsior
Treatment of pulmonary embolism data from registries - prof. Zbigniew GąsiorTreatment of pulmonary embolism data from registries - prof. Zbigniew Gąsior
Treatment of pulmonary embolism data from registries - prof. Zbigniew Gąsior
 
Therapeutic options for aortic stenosis in elderly - dr Jaroslaw Trębacz
Therapeutic options for aortic stenosis in elderly - dr Jaroslaw TrębaczTherapeutic options for aortic stenosis in elderly - dr Jaroslaw Trębacz
Therapeutic options for aortic stenosis in elderly - dr Jaroslaw Trębacz
 
Renal stenting and denervation - prof. Tadeusz Przewłocki
Renal stenting and denervation - prof. Tadeusz PrzewłockiRenal stenting and denervation - prof. Tadeusz Przewłocki
Renal stenting and denervation - prof. Tadeusz Przewłocki
 
Renal denervation - prof. Adam Witkowski
Renal denervation - prof. Adam WitkowskiRenal denervation - prof. Adam Witkowski
Renal denervation - prof. Adam Witkowski
 
Regenerative therapies for heart and vessels - prof. Piotr Musiałek
Regenerative therapies for heart and vessels - prof. Piotr MusiałekRegenerative therapies for heart and vessels - prof. Piotr Musiałek
Regenerative therapies for heart and vessels - prof. Piotr Musiałek
 
Patient with chronic PE treatment options - dr Szymon Darocha
Patient with chronic PE treatment options - dr Szymon DarochaPatient with chronic PE treatment options - dr Szymon Darocha
Patient with chronic PE treatment options - dr Szymon Darocha
 
Novel self expanding nitinol carotid stent - dr Krzysztof Milewski
Novel self expanding nitinol carotid stent - dr Krzysztof MilewskiNovel self expanding nitinol carotid stent - dr Krzysztof Milewski
Novel self expanding nitinol carotid stent - dr Krzysztof Milewski
 
Novel paclitaxel coated balloon - dr Piotr Buszman
Novel paclitaxel coated balloon - dr Piotr BuszmanNovel paclitaxel coated balloon - dr Piotr Buszman
Novel paclitaxel coated balloon - dr Piotr Buszman
 
New perspectives in CLI - prof. Giancarlo Biamino
New perspectives in CLI - prof. Giancarlo BiaminoNew perspectives in CLI - prof. Giancarlo Biamino
New perspectives in CLI - prof. Giancarlo Biamino
 
Limitations of carotid stenting - dr Antoni Ferens
Limitations of carotid stenting - dr Antoni FerensLimitations of carotid stenting - dr Antoni Ferens
Limitations of carotid stenting - dr Antoni Ferens
 
LAA ligation and ablation - dr Marcin Kuniewicz
LAA ligation and ablation - dr Marcin KuniewiczLAA ligation and ablation - dr Marcin Kuniewicz
LAA ligation and ablation - dr Marcin Kuniewicz
 
LAA closure - prof. Jaroslav Januska
LAA closure - prof. Jaroslav JanuskaLAA closure - prof. Jaroslav Januska
LAA closure - prof. Jaroslav Januska
 
LAA closure - dr Marek Grygier
LAA closure - dr Marek GrygierLAA closure - dr Marek Grygier
LAA closure - dr Marek Grygier
 
Hypoplastic left heart syndome - prof. Tomasz Moszura
Hypoplastic left heart syndome - prof. Tomasz MoszuraHypoplastic left heart syndome - prof. Tomasz Moszura
Hypoplastic left heart syndome - prof. Tomasz Moszura
 
Historia HLHS - prof. Janusz Skalski
Historia HLHS - prof. Janusz SkalskiHistoria HLHS - prof. Janusz Skalski
Historia HLHS - prof. Janusz Skalski
 
Generalised atherosclerosis - dr Antonio Micari
Generalised atherosclerosis - dr Antonio MicariGeneralised atherosclerosis - dr Antonio Micari
Generalised atherosclerosis - dr Antonio Micari
 
Decision making for pulmonary embolism - dr Michal Chyrchel
Decision making for pulmonary embolism - dr Michal ChyrchelDecision making for pulmonary embolism - dr Michal Chyrchel
Decision making for pulmonary embolism - dr Michal Chyrchel
 

Diagnostic standards for PE - prof. Tomasz Rakowski

  • 1. diagnostic standards for pulmonary embolism Tomasz Rakowski Jagiellonian University Medical College Krakow, Poland
  • 2.
  • 3. Diagnosis Throughout these guidelines and for the purpose of clinical management, ‘confirmed PE’ is understood as a probability of PE high enough to indicate the need for PE-specific treatment and ‘excluded PE’ as a probability of PE low enough to justify withholding specific PE-treatment with an acceptably low risk despite a clinical suspicion of PE. These terms are not meant to indicate absolute certainty regarding the presence or absence of embolii in the pulmonary arterial bed. .
  • 4.
  • 5. Severity of pulmonary embolism The severity of PE should be understood as an individual estimate of PE-related early mortality risk rather than the anatomical burden and the shape and distribution of intrapulmonary emboli. Therefore, current guidelines suggest replacing potentially misleading terms such as ‘massive’, ‘submassive’ and ‘non-massive’ with the estimated level of the risk of PE-related early death.
  • 6. Principal markers useful for risk stratification
  • 7. Risk stratification according to expected pulmonary embolism-related early mortality rate a In the presence of shock or hypotension it is not necessary to confirm RV dysfunction/injury to classify as high risk of PE-related early mortality.
  • 8.
  • 9.
  • 10. Clinical prediction rules for PE Revised Geneva score Wells score
  • 11. Simplified clinical prediction rules for PE Revised Geneva score Wells score +1 +1 +1 +1 +1 +1 +1 +1 +1 +1 +1 +1 +1 +1 +1 +1 Low: 0 to 1; intermediate: 2 to 4; high: 5+ PE unlikely: 0 to 1; PE likely: 2 or more PE unlikely: 0 to 2; PE likely: 3 or more Thromb Haemost 2009;101:197-200 Arch Intern Med. 2008;168:2131-6
  • 12.
  • 13.
  • 14. Validated diagnostic criteria for diagnosing PE in patients without shock and hypotension (non-high-risk PE) according to clinical probability
  • 15. Validated diagnostic criteria for diagnosing PE in patients without shock and hypotension (non-high-risk PE) according to clinical probability